13058_2020_1286_MOESM10_ESM.xlsx (13.93 kB)
Download fileAdditional file 10 of Antitumor activity of Z-endoxifen in aromatase inhibitor-sensitive and aromatase inhibitor-resistant estrogen receptor-positive breast cancer
dataset
posted on 2020-05-20, 03:49 authored by Swaathi Jayaraman, Xiaonan Hou, Mary J. Kuffel, Vera J. Suman, Tanya L. Hoskin, Kathryn E. Reinicke, David G. Monroe, Krishna R. Kalari, Xiaojia Tang, Megan A. Zeldenrust, Jingfei Cheng, Elizabeth S. Bruinsma, Sarah A. Buhrow, Renee M. McGovern, Stephanie L. Safgren, Chad A. Walden, Jodi M. Carter, Joel M. Reid, James N. Ingle, Matthew M. Ames, John R. Hawse, Matthew P. GoetzAdditional file 10. Ingenuity pathway analysis (IPA) indicating key molecular, cellular and signaling pathways likely impacted by Z-endoxifen treatment in the MCF7LR tumors.
Funding
Mayo Clinic Breast Cancer Specialized Program of Research Excellence Grant National Institute of Arthritis and Musculoskeletal and Skin Diseases Prospect Creek Foundation George M. Eisenberg Foundation for Charities The Regis Foundation National Institutes of Health
History
References
- 10.1007/s00280-004-0926-7
- 10.1023/B:BREA.0000025406.31193.e8
- 10.1158/0008-5472.CAN-08-3933
- 10.1093/jnci/djg108
- 10.1016/j.clpt.2006.03.013
- 10.1093/jnci/dji005
- 10.1007/s00280-014-2605-7
- 10.1007/s10549-013-2530-1
- 10.1200/JCO.2017.73.3246
- 10.1093/jnci/djh076
- 10.1158/0008-5472.CAN-07-6807
- 10.1158/0008-5472.CAN-15-0709
- 10.1677/erc.1.01257
- 10.1016/j.yexcr.2004.08.015
- 10.1073/pnas.0506580102
- 10.1186/1471-2105-14-7
- 10.1371/journal.pone.0098219
- 10.1210/er.2011-1057
- 10.1007/s10555-016-9637-x
- 10.5306/wjco.v7.i5.352
